When treating cases of blood poisoning, doctors resort immediately to broad-spectrum antibiotics. The problem is that in many cases the bacteria are resistant to the medicine. Analyzing antibiotic resistance is a time-consuming process, and for many patients the results come too late. Now a new technique that supplies results in just nine hours is to be presented at the Biotechnica trade show in Hanover from October 6-8 (Hall 9, booth C34).
For patients with blood poisoning, also known as septicemia, every second counts. Doctors who suspect a patient has sepsis start them on broad-spectrum antibiotics right away, but the antibiotics don’t always have the desired effect – for instance if the bacteria are resistant to the medicines used.
Identifying the pathogens in the lab and investigating their potential resistance routinely takes between 60 and 100 hours. This is time the patient simply doesn’t have – most cases end fatally within around 48 hours. Blood poisoning accounts for 60,000 deaths a year in Germany alone.
Test results in nine hours
In future, this analysis could take much less time – saving many patients’ lives. Once doctors know whether the bacteria are resistant to certain substances, they can treat the patient with a targeted antibiotic that reliably kills off the pathogen.
This is possible thanks to a technology developed by the researchers at the Fraunhofer Institutes for Applied Information Technology FIT and for Laser Technology ILT in collaboration with the Uniklinikum Aachen and numerous industry partners. “Our testing method yields results in just nine hours,” says Professor Harald Mathis, department head at Fraunhofer FIT.
So how are researchers now able to analyze the bacteria in a blood sample up to ten times faster than before? “We’ve developed a miniaturized system with a patented optical design,” reveals Mathis. The first step is to mark the pathogens indicative of septicemia, so that they glow when exposed to laser light. This then allows the researchers to assess the amount of bacteria present in the blood.
In the next stage of the process, the bacteria are separated from the blood and channeled into a series of miniaturized dishes. Each contains a culture medium that includes a specific antibiotic. A second optical system complete with the necessary analysis software observes and precisely documents how the bacteria develop.
Then comes the key step: algorithms analyze the pictures taken of the bacteria and extrapolate the growth curve, meaning the researchers can see within hours whether the respective medicine is working or whether the bacteria are resistant to it and spreading rapidly. Essentially, the growth monitor software is able to calculate and predict how bacteria will develop over time.
It does so by analyzing both the extent of the bacterial growth – which provides a one-to-one indication of the number of bacteria present – and the ratio of living to dead bacteria. In short: This tells researchers which antibiotic will be most effective in killing off the bacteria – and help the patient the most.
Researchers will be showcasing a prototype of the growth monitor at the Biotechnica trade show in Hanover from October 6-8 (Hall 9, booth C34).
Birgit Niesing | Fraunhofer-Gesellschaft
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences